Intelligent Medicine Acquisition Corp. Announces It Will Redeem Its Public Shares
Intelligent Medicine Acquisition Corp. (NASDAQ:IQMD) (the “Company”), a blank-check company formed for the purpose of acquiring or merging with one or more businesses, today announced that because...
Intelligent Medicine Acquisition Corp. Announces Adjournment of Special Meeting of Stockholders
Intelligent Medicine Acquisition Corp. (Nasdaq: IQMD) (the “Company”) announced today that it has postponed the Company’s Special Meeting of Stockholders to be held on February 3, 2023, at 9:30 a.m....
Kroll Appoints Patience Marime-Ball as Senior Advisor to Kroll’s ESG Advisory Services
Kroll , the leading provider of data, technology and insights related to risk, governance and growth, announced today Patience Marime-Ball will be a Senior Advisor to Kroll’s Environmental, Social and...